Published On : July 2026
Not every cardiovascular service line participates in the cardiovascular healthcare value-based care models market the same way. Some, like interventional cardiology, map naturally onto discrete, high-cost episodes that lend themselves to bundled payment. Others, like preventive cardiology, generate value primarily by avoiding costly events over time, which fits far more comfortably inside shared-savings or capitation frameworks. This page walks through each of the five major service lines and how value-based structures apply to each.
The common thread across all five is that value-based participation rewards service lines that can demonstrate measurable, attributable improvements in cost or outcomes, which is why data infrastructure and care coordination increasingly matter as much as clinical volume in determining which service lines lead a cardiology group's value-based strategy.
Interventional cardiology, centered on percutaneous coronary intervention and stent placement, is the service line most directly tied to bundled payment structures because its episodes are well-defined, high-volume, and high-cost, making them easy to price and track. Hospitals and cardiology groups managing PCI episodes under bundled payment structures used for PCI and CABG episodes focus heavily on reducing unnecessary length of stay, avoiding preventable complications, and steering patients toward efficient post-acute pathways when needed.
Because interventional procedures represent some of the largest single line items in cardiovascular spending, this service line has historically attracted the earliest and most detailed CMS attention, from the original Acute Myocardial Infarction and CABG episode models to current mandatory bundle expansions, making it the most mature service line from a value-based contracting standpoint.
Electrophysiology, covering atrial fibrillation management and device implantation such as pacemakers and defibrillators, participates in value-based care somewhat differently than interventional cardiology. Device implantation procedures can be bundled similarly to PCI, but ongoing AFib management is a longitudinal condition better suited to shared-savings or capitation arrangements that reward sustained anticoagulation adherence and stroke-risk reduction rather than a single procedural episode.
Providers managing electrophysiology populations under value-based contracts increasingly rely on remote cardiac monitoring to catch arrhythmia recurrence early, since a single missed AFib episode leading to a stroke or hospitalization can erase the savings generated by dozens of well-managed patients. This makes electrophysiology one of the service lines where monitoring technology adoption most directly affects value-based contract performance.
Heart failure management is the fastest-growing service line within the broader market, reflecting both the chronic, recurring cost burden that heart failure patients generate and the strong evidence base showing that structured post-discharge monitoring meaningfully reduces readmissions. Heart failure episodes fit well inside shared-savings and two-sided risk arrangements because the financial upside from readmission avoidance is large and relatively easy to measure against historical baselines.
A typical heart failure value-based program combines medication titration support, remote weight and symptom monitoring, and rapid outpatient follow-up after any hospitalization. Organizations that execute this combination well can generate outsized shared-savings performance relative to other service lines, which is a significant reason heart failure programs have become a strategic priority for both hospital-employed and independent cardiology groups entering value-based contracts.
Preventive cardiology, spanning hypertension control, lipid management, and broader chronic cardiovascular disease prevention, is the service line most aligned with capitation and shared-savings models because its financial value comes almost entirely from events that never happen. Organizations built around this approach, including physician-led platforms like ChenMed and Oak Street Health specializing in preventive cardiology, integrate cardiovascular risk factor management directly into routine primary care visits rather than treating it as a separate specialty referral.
This service line has historically been under-resourced relative to procedural cardiology, since fee-for-service reimbursement rewards volume of intervention rather than avoidance of it. Value-based arrangements invert that incentive, which is a core reason preventive cardiology is attracting growing attention from payors and provider organizations building longer-term risk strategies.
Cardiac imaging and diagnostics, including echocardiography, stress testing, and advanced cardiac imaging modalities, plays a supporting rather than a standalone role in most value-based cardiology arrangements. Rather than carrying its own dedicated payment structure, imaging utilization is typically managed as a cost and quality lever embedded within ACO, bundled payment, or capitation contracts covering broader cardiac episodes or populations.
Appropriate use criteria and utilization management have become central tools for controlling imaging-related spending inside value-based arrangements, since imaging costs can vary widely without necessarily translating into better outcomes. Organizations managing capitated or two-sided risk populations increasingly track imaging utilization patterns closely, both to control cost and to ensure that diagnostic testing intensity matches actual clinical need rather than historical referral habits.